Report data from the treatment phase of the CATALYST study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Jul 2024
- Due
- 31 Dec 2024
- Delivered
- 12 Dec 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We expect data from the treatment phase of the CATALYST study, as well as our other late-stage studies, GRADIENT, ROSELLA and DAZALS, by the end of this year”
What we found
Evidence strength B What the grades mean
Corcept released topline data from CATALYST treatment phase on December 12, 2024, before the year-end 2024 deadline, showing positive primary endpoint results.
-
B Corcept Announces Positive Results in Treatment Phase of CATALYST Trial
“CATALYST met its primary endpoint. Patients who received Korlym exhibited a clinically meaningful and statistically significant improvement in hemoglobin A1c”
-
B Corcept Announces Positive Results in Treatment Phase of CATALYST Trial
“December 12, 2024-- Corcept Therapeutics Incorporated (NASDAQ: CORT)...today announced that the primary endpoint was met in the treatment phase of CATALYST”
Checked 7 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- CATALYST treatment phase data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Corcept Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-CORT-002900 · Corrections policy